vs
Side-by-side financial comparison of BGSF, INC. (BGSF) and Ceribell, Inc. (CBLL). Click either name above to swap in a different company.
Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $22.0M, roughly 1.1× BGSF, INC.). BGSF, INC. runs the higher net margin — -5.3% vs -54.6%, a 49.3% gap on every dollar of revenue. BGSF, INC. produced more free cash flow last quarter ($1.7M vs $-11.0M).
BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
BGSF vs CBLL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.0M | $24.8M |
| Net Profit | $-1.2M | $-13.5M |
| Gross Margin | 35.0% | 87.3% |
| Operating Margin | -17.6% | -58.9% |
| Net Margin | -5.3% | -54.6% |
| Revenue YoY | -9.4% | — |
| Net Profit YoY | -18.2% | — |
| EPS (diluted) | $-0.12 | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.0M | $24.8M | ||
| Q3 25 | $26.9M | $22.6M | ||
| Q2 25 | $23.5M | $21.2M | ||
| Q1 25 | $20.9M | $20.5M | ||
| Q4 24 | $24.3M | — | ||
| Q3 24 | $29.8M | $17.2M | ||
| Q2 24 | $25.7M | — | ||
| Q1 24 | $24.5M | — |
| Q4 25 | $-1.2M | $-13.5M | ||
| Q3 25 | $-5.8M | $-13.5M | ||
| Q2 25 | $-3.7M | $-13.6M | ||
| Q1 25 | $-722.0K | $-12.8M | ||
| Q4 24 | $-981.0K | — | ||
| Q3 24 | $-804.0K | $-10.4M | ||
| Q2 24 | $-761.0K | — | ||
| Q1 24 | $-792.0K | — |
| Q4 25 | 35.0% | 87.3% | ||
| Q3 25 | 35.9% | 88.3% | ||
| Q2 25 | 35.8% | 88.1% | ||
| Q1 25 | 36.2% | 87.9% | ||
| Q4 24 | 35.9% | — | ||
| Q3 24 | 35.9% | 87.3% | ||
| Q2 24 | 37.3% | — | ||
| Q1 24 | 38.1% | — |
| Q4 25 | -17.6% | -58.9% | ||
| Q3 25 | -3.5% | -64.8% | ||
| Q2 25 | -18.8% | -70.5% | ||
| Q1 25 | 1.6% | -69.3% | ||
| Q4 24 | -15.7% | — | ||
| Q3 24 | -3.4% | -57.8% | ||
| Q2 24 | -5.7% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | -5.3% | -54.6% | ||
| Q3 25 | -21.6% | -59.6% | ||
| Q2 25 | -15.9% | -64.4% | ||
| Q1 25 | -3.5% | -62.4% | ||
| Q4 24 | -4.0% | — | ||
| Q3 24 | -2.7% | -60.6% | ||
| Q2 24 | -3.0% | — | ||
| Q1 24 | -3.2% | — |
| Q4 25 | $-0.12 | $-0.35 | ||
| Q3 25 | $-0.52 | $-0.37 | ||
| Q2 25 | $-0.34 | $-0.38 | ||
| Q1 25 | $-0.06 | $-0.36 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.07 | $-1.85 | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $159.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $48.1M | $155.3M |
| Total Assets | $57.8M | $195.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $159.3M | ||
| Q3 25 | $41.2M | $168.5M | ||
| Q2 25 | $2.8M | $177.4M | ||
| Q1 25 | $2.0M | $182.7M | ||
| Q4 24 | $32.0K | — | ||
| Q3 24 | $262 | $14.1M | ||
| Q2 24 | $226 | — | ||
| Q1 24 | $50 | — |
| Q4 25 | $48.1M | $155.3M | ||
| Q3 25 | $50.7M | $164.1M | ||
| Q2 25 | $78.3M | $172.2M | ||
| Q1 25 | $81.8M | $180.9M | ||
| Q4 24 | $82.3M | — | ||
| Q3 24 | $82.9M | $-136.0M | ||
| Q2 24 | $83.2M | — | ||
| Q1 24 | $83.6M | — |
| Q4 25 | $57.8M | $195.8M | ||
| Q3 25 | $83.6M | $199.5M | ||
| Q2 25 | $149.7M | $207.7M | ||
| Q1 25 | $152.3M | $213.5M | ||
| Q4 24 | $150.1M | — | ||
| Q3 24 | $157.3K | $47.1M | ||
| Q2 24 | $159.8K | — | ||
| Q1 24 | $170.6K | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7M | $-10.8M |
| Free Cash FlowOCF − Capex | $1.7M | $-11.0M |
| FCF MarginFCF / Revenue | 7.6% | -44.2% |
| Capex IntensityCapex / Revenue | 0.1% | 0.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0K | $-41.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $-10.8M | ||
| Q3 25 | $-4.8M | $-11.1M | ||
| Q2 25 | $2.2M | $-7.5M | ||
| Q1 25 | $1.1M | $-11.4M | ||
| Q4 24 | $3.2M | — | ||
| Q3 24 | $6.5M | — | ||
| Q2 24 | $7.3M | — | ||
| Q1 24 | $7.4M | — |
| Q4 25 | $1.7M | $-11.0M | ||
| Q3 25 | $-4.9M | $-11.5M | ||
| Q2 25 | $2.1M | $-7.6M | ||
| Q1 25 | $1.0M | $-11.6M | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $6.5M | — | ||
| Q2 24 | $7.3M | — | ||
| Q1 24 | $6.9M | — |
| Q4 25 | 7.6% | -44.2% | ||
| Q3 25 | -18.1% | -50.8% | ||
| Q2 25 | 9.1% | -35.9% | ||
| Q1 25 | 5.0% | -56.4% | ||
| Q4 24 | 10.2% | — | ||
| Q3 24 | 21.7% | — | ||
| Q2 24 | 28.5% | — | ||
| Q1 24 | 28.1% | — |
| Q4 25 | 0.1% | 0.7% | ||
| Q3 25 | 0.4% | 1.6% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.1% | 0.7% | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 2.0% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
